The iM80 is the 15-inch flagship of Edan's second-generation iM patient monitor series, positioned for high-acuity bedside and transport monitoring. It pairs a 1024 x 768 touch display and 13-waveform capacity with Edan's iSEAP ECG, SEMIP 12-lead, iMAT SpO2 and iCUFS NIBP algorithms, plus optional invasive blood pressure, cardiac output, capnography and anaesthetic gas modules. Built-in Wi-Fi/LAN, HL7/XML connectivity and dual hot-swap 4.2 Ah batteries make it a full critical-care platform.
Highlights
- 15-inch color TFT touch screen, 1024 x 768 resolution, up to 13 simultaneous waveforms
- 1200 NIBP measurement review, 120 h trends, 200 alarm review and 48 h full disclosure
- Dual 4.2 Ah batteries run 240 min or longer; a single battery runs 120 min or longer
- Supports up to 4 IBP channels with ICP and cardiac output, plus sidestream CO2 at 50 ml/min
- SEMIP 12-lead diagnosis algorithm; iSEAP ECG and iMAT SpO2 processing
- Fanless chassis measuring 370 x 175 x 320 mm and weighing under 7 kg without battery
Technical parameters
Display
| Screen | 15 inch color TFT, touch screen |
|---|
| Resolution | 1024 x 768 pixels |
|---|
| Maximum waveforms | Up to 13 simultaneous waveforms |
Parameters
| Standard parameters | 3/5-lead ECG, RESP, SpO2, NIBP, PR, 2-TEMP |
|---|
| Optional parameters | - 6/12-lead ECG
- Nellcor SpO2
- SunTech NIBP
- 4-IBP (ICP)
- C.O.
- G2 sidestream CO2
- Respironics CO2
- Masimo CO2/AG/O2
- Drager AG/O2
|
|---|
| ECG heart rate range | - Adult 15-300 bpm
- pediatric/neonatal 15-350 bpm
- accuracy +/-1% or +/-1 bpm
|
|---|
| Respiration (RESP) | Trans-thoracic impedance; adult 0-120 rpm, neonatal/pediatric 0-150 rpm |
|---|
| NIBP range (adult) | SYS 40-270 mmHg, DIA 10-215 mmHg, MAP 20-235 mmHg; accuracy +/-5 mmHg |
|---|
| SpO2 | 0-100%; accuracy +/-2% (70-100%) adult/pediatric, +/-3% neonate |
|---|
| Temperature | 2 channels, 0-50 C, resolution 0.1 C, accuracy +/-0.1 C |
|---|
| IBP channels and range | Up to 4 channels; P1/P2 -50 to +300 mmHg, Art 0-300 mmHg, PA -6 to +120 mmHg, CVP/RAP/LAP/ICP -10 to +40 mmHg |
|---|
| EtCO2 range | 0-150 mmHg (G2 sidestream); Respironics sidestream sample flow 50 +/-10 ml/min |
|---|
| Cardiac output (C.O.) | Thermodilution, 0.1-20 L/min; accuracy +/-5% or 0.2 L/min |
Alarms
| Alarm review capacity | Up to 200 alarm events |
|---|
| Apnea alarm delay | 10/15/20/25/30/35/40 s (default 20 s) |
Trends
| Trend review | 120 h at 1-min resolution; 1 h at 1-s resolution |
|---|
| Full disclosure | 48 h WaveReview |
|---|
| NIBP measurement review | 1200 sets |
Connectivity
| Network and integration | - Built-in Wi-Fi and LAN
- HL7/XML to HIS
- central station
- Nurse Call
- VGA output
- defibrillator sync
- barcode scanner
|
|---|
| Ports | - 2 x USB host + 1 x USB device (USB 2.0)
- 10/100 M Ethernet
- VGA
- PS/2
- thermal recorder output
|
Physical
| Dimensions | 370 mm (L) x 175 mm (W) x 320 mm (H) |
|---|
| Weight | Under 7 kg (standard configuration, without battery) |
|---|
| Ingress protection | IPX1 |
Power
| Power supply | 100-240 V~, 50/60 Hz, 1.4 A-0.7 A; fuse T 1.6AL 250 V |
|---|
| Battery | 4.2 Ah; one battery 120 min or longer, two batteries 240 min or longer |
Regulatory
| Device classification | Class I internally powered; ECG/TEMP/IBP/C.O. type CF, SpO2/NIBP/CO2/AG type BF |
|---|
| Standards | - IEC/EN 60601-1
- 60601-1-2
- 60601-2-27
- -2-30
- -2-34
- -2-49
- -2-25 and -2-51 (iM80); ANSI/AAMI EC13 and SP10
|
Applications
- Intensive care units (ICU)
- Coronary care units (CCU)
- Operating rooms and post-anaesthesia care units (PACU)
- Emergency departments and resuscitation rooms
- Cardiac catheterisation and haemodynamics laboratories
- Neonatal and paediatric intensive care
- General wards and step-down units
- Intra-hospital patient transport monitoring
Manufacturer
Edan Instruments, Inc., Shenzhen, Guangdong · https://www.edan.com
Edan Instruments, Inc. is a Shenzhen-based medical device manufacturer founded in 1995 and listed on the Shenzhen Stock Exchange ChiNext (300206). It develops patient monitoring and life support, diagnostic ECG, obstetrics/gynecology, ultrasound imaging, point-of-care testing and in-vitro diagnostics, with over 100 products sold in more than 170 countries. The company operates four global R&D centres and reported revenue of roughly RMB 1.83-2.00 billion for 2024-2025.
Sources
- https://web.archive.org/web/2024id_/https://www.edan.com/Uploads/20230525023425_678089.pdf
- https://www.edan.com/product/m/PM_iM_Series_(iM80/70/60/50).html
- https://web.archive.org/web/20240418034452id_/https://edan.com/ContactUs/
- https://www.youtube.com/watch?v=TBFCcWEGSYI